- Home
- AVTX vs DMO Comparison
AVTX vs DMO Comparison
Compare AVTX & DMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- DMO
- Stock Information
- Founded
- AVTX 2011
- DMO 2009
- Country
- AVTX United States
- DMO United States
- Employees
- AVTX N/A
- DMO N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- DMO Trusts Except Educational Religious and Charitable
- Sector
- AVTX Health Care
- DMO Finance
- Exchange
- AVTX Nasdaq
- DMO Nasdaq
- Market Cap
- AVTX 138.8M
- DMO 135.9M
- IPO Year
- AVTX 2015
- DMO N/A
- Fundamental
- Price
- AVTX $13.50
- DMO $11.86
- Analyst Decision
- AVTX Strong Buy
- DMO
- Analyst Count
- AVTX 9
- DMO 0
- Target Price
- AVTX $30.14
- DMO N/A
- AVG Volume (30 Days)
- AVTX 451.4K
- DMO 49.6K
- Earning Date
- AVTX 11-06-2025
- DMO 01-01-0001
- Dividend Yield
- AVTX N/A
- DMO 12.06%
- EPS Growth
- AVTX N/A
- DMO N/A
- EPS
- AVTX N/A
- DMO N/A
- Revenue
- AVTX $441,000.00
- DMO N/A
- Revenue This Year
- AVTX N/A
- DMO N/A
- Revenue Next Year
- AVTX N/A
- DMO N/A
- P/E Ratio
- AVTX N/A
- DMO N/A
- Revenue Growth
- AVTX N/A
- DMO N/A
- 52 Week Low
- AVTX $3.39
- DMO $10.00
- 52 Week High
- AVTX $16.00
- DMO $11.80
- Technical
- Relative Strength Index (RSI)
- AVTX 65.78
- DMO 51.07
- Support Level
- AVTX $12.41
- DMO $11.72
- Resistance Level
- AVTX $14.73
- DMO $11.88
- Average True Range (ATR)
- AVTX 0.94
- DMO 0.11
- MACD
- AVTX 0.13
- DMO -0.00
- Stochastic Oscillator
- AVTX 70.97
- DMO 45.56
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About DMO Western Asset Mortgage Opportunity Fund Inc.
Western Asset Mortgage Defined Opportunity Fund Inc is a non-diversified, limited-term, closed-end management investment company. The fund's primary investment objective is to provide current income. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing in a diverse portfolio of mortgage-backed securities, consisting of non-agency residential mortgage-backed securities and commercial mortgage-backed securities.